Auricular points acupressure for insulin resistance in overweight/obese women with polycystic ovary syndrome: protocol for a randomised controlled pilot trial

التفاصيل البيبلوغرافية
العنوان: Auricular points acupressure for insulin resistance in overweight/obese women with polycystic ovary syndrome: protocol for a randomised controlled pilot trial
المؤلفون: Songjiang Liu, Yangyang Li, Lihui Hou, Zimeng Pan, Yan Li, Liangzhen Xie, Yingji Wang, Mei-Wei Zhang, Yicheng Ding, Yufang Qu, Miao Sun
المصدر: BMJ Open
بيانات النشر: BMJ, 2019.
سنة النشر: 2019
مصطلحات موضوعية: Adult, medicine.medical_specialty, Adolescent, Pilot Projects, Acupressure, Overweight, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Insulin resistance, Quality of life, Informed consent, auricular points acupressure, insulin resistance, Internal medicine, Obstetrics and Gynaecology, Protocol, Acupuncture, Humans, Medicine, Obesity, business.industry, Ear, General Medicine, medicine.disease, Polycystic ovary, 030205 complementary & alternative medicine, Treatment Outcome, Research Design, polycystic ovary syndrome, 030220 oncology & carcinogenesis, Female, medicine.symptom, business, Body mass index, Follow-Up Studies
الوصف: IntroductionApproximately 5%–20% of reproductive women suffer from polycystic ovary syndrome (PCOS). Auricular points acupressure (AA) may serve as alternative management for PCOS for its benefits in both physical and psychological well-being. However, the effects of AA for insulin resistance (IR) in overweight/obese PCOS women have not been confirmed.Methods and analysisThe present study is designed as a randomised, placebo-controlled pilot trial to evaluate the effectiveness and safety of AA in treating IR in women with PCOS. A total of 60 eligible PCOS subjects will be randomised into an intervention group (AA group) and a control group (sham AA group) in a ratio of 1:1. Magnetic beads will be taped to the auricular points by the same senior acupuncture specialist from the First Affiliated Hospital, Heilongjiang University of Chinese Medicine. The treatment will last for 12 weeks. Primary outcome measure will be changes in homeostasis model assessment of IR between baseline and after 3 months of AA/sham AA treatment. Secondary outcomes include hormonal profile, weight, waist/hip circumference, body mass index, blood pressure, Ferriman-Gallwey score, acne and the assessment of health-related quality of life. Outcome measures are collected at baseline and the end of treatment visit.Ethics and disseminationThe protocol has been approved by the ethics committee of the First Affiliated Hospital of Heilongjiang University of Chinese Medicine (HZYLLKY201800301). Written informed consent will be obtained from all participants. The results will be disseminated through peer-reviewed journals for publications.Trial registration numberNCT03546595; Pre-results.
تدمد: 2044-6055
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129a89322a80926b628c5f8a45ec5db6
https://doi.org/10.1136/bmjopen-2018-027498
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....129a89322a80926b628c5f8a45ec5db6
قاعدة البيانات: OpenAIRE